Period:
Draw Mode:
| Volume | 4,987,927 |
|
|||||
| News | - | ||||||
| Day High | 1.14 | Low High |
|||||
| Day Low | 1.06 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bionano Genomics Inc | BNGO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.05 | -4.42% | 1.08 | 19:44:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.13 | 1.06 | 1.14 | 1.08 | 1.13 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,168 | 4,987,927 | $ 1.11 | $ 5,515,695 | - | 1.06 - 4.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:55 | 10 | $ 1.08 | USD |
Bionano Genomics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 330.74M | 306.24M | 306.06M | $ 27.80M | $ - | -0.46 | -3.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 2.00% |
Bionano Genomics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BNGO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.18 | 1.28 | 1.06 | 1.20 | 6,568,963 | -0.10 | -8.47% |
| 1 Month | 1.49 | 1.49 | 1.06 | 1.29 | 6,568,587 | -0.41 | -27.52% |
| 3 Months | 1.50 | 2.02 | 1.06 | 1.56 | 6,586,177 | -0.42 | -28.0% |
| 6 Months | 2.14 | 3.01 | 1.06 | 1.90 | 6,993,497 | -1.06 | -49.53% |
| 1 Year | 2.37 | 4.35 | 1.06 | 2.06 | 7,164,561 | -1.29 | -54.43% |
| 3 Years | 0.425 | 15.685 | 0.25 | 4.63 | 17,079,077 | 0.655 | 154.12% |
| 5 Years | 10.00 | 15.685 | 0.25 | 4.51 | 11,934,537 | -8.92 | -89.2% |
Bionano Genomics Description
| Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. |